Skip to Main Content

Paper Details

Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells.
Anticancer Res
0
2023
-, 5, 5-FU, 5-FU resistant cell, 5-Fluorouracil, AKT, EAC, EAC cells, EAC tumors, ERK, Esophageal Adenocarcinoma, Esophageal Adenocarcinoma Cells, FLO-1, GPC, GPC-1, Glypican-1, cancer, catenin, esophageal adenocarcinoma, patients
Author NameAffiliation
Sachin WaniUniversity of Colorado Anschutz Medical Campus
Robert A MeguidUniversity of Colorado Anschutz Medical Campus
  • 1 - 2

Datasets

Release 1.2